ClearPoint Neuro Earnings Call Highlights Growth and Investment
ClearPoint Neuro (CLPT) reported Q3 revenue of $12.1M, up 36% YoY. Growth was driven by navigation, capital equipment, and biologics. Margins fell to 58% due to overhead and amortization. The company raised $22M to support expansion and integration. Management expects continued growth but cautioned about cash burn and regulatory risks.
